Condition: Breast Cancer Female · Sponsor: University Hospital Schleswig-Holstein
In the randomized DAI-BREAC trial, a reminder app will be prospectively tested that reminds breast cancer patients four times each day to perform the required skin care. This will likely contribute to the reduction of grade ≥2 radiation dermatitis in these patients. A total of 268 patients will be randomized to receive standard skin care supported by a reminder app (Arm A) or standard skin care alone (Arm B). Stratification will be done using the three factors treatment volume, radiation boost, and at least one risk factor of dermatitis. Secondary aims include pain (radiation fields), patient satisfaction with the reminder app (Arm A only), impact of the app on the use of health technology (Arm A only), and benefit from support by staff members of the treating Department of Radiation Oncology and/or the UKSH academy regarding the use of the app (Arm A only).
This description comes directly from the study's public registry record.
Dirk Rades, MD, FASTRO · 0049-451-500 · DIRK.RADES@UKSH.DE
Carlos A. Narvaez-Wolf, MD · 0049-451-500 · Carlos.Narvaez-Wolf@uksh.de
Always discuss trial participation with your own doctor first.
| Vejle Hospital, University Hospital of Southern Denmark | Vejle, Southern Denmark, Denmark | Not Yet Recruiting |
| Medical Practice for Radiotherapy and Radiation Oncology | Hanover, Lower Saxony, Germany | Not Yet Recruiting |
| Medical School Hamburg, Schwerin Campus | Schwerin, Mecklenburg-Vorpommern, Germany | Not Yet Recruiting |
| Malteser Hospital St. Franziskus | Flensburg, Schleswig-Holstein, Germany | Not Yet Recruiting |
| Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein | Lübeck, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06483477